ICICI Prudential: Will Prudential’s 12% stake sell affect the company’s business?

Synopsis: Prudential plc’s planned 12% stake sale in ICICI Prudential Life may weigh on the stock in the near term. However, strong growth prospects, improving VNB margins, and expected 11% APE growth continue to support the company’s long-term outlook.

The shares of the company offer a wide range of products including term insurance, savings plans, ULIPs, retirement solutions, and health insurance products are in the spotlight after Emkay gave an upside target of 34 percent.

With a market capitalisation of Rs. 75,828 cr, the shares of ICICI Prudential Life Insurance Company Ltd were trading at Rs. 522 per share, up from its previous close of Rs. 515.75 per share. The stock has delivered negative returns across multiple time periods, declining 16% over the past year, 23% year-to-date, 15% in the last six months, and 6% over the past month.

Emkay Commentary 

Emkay has maintained its ‘Add’ rating on ICICI Prudential Life Insurance Company Ltd with a target price of Rs. 700, implying an upside potential of nearly 34% from current levels. The brokerage highlighted that Prudential plc has expressed its intention to sell at least around 12% stake in the company.

While the proposed stake sale may create a near-term overhang on the stock price, Emaky expects limited operational impact on the business. However, it noted that the SCB partnership could face some risk following the transaction.

The brokerage remains positive on the company’s medium-term outlook, expecting a gradual improvement in VNB margins over FY27E–FY29E. It also forecasts around 11% APE growth for FY27E, supported by improving business momentum and distribution strength.

In conclusion, Prudential’s planned stake sale in ICICI Prudential Life may create a short-term overhang on the stock due to potential supply pressure and investor sentiment concerns. However, the company’s strong growth outlook, supported by improving VNB margins, expected APE growth, and stable operational fundamentals, suggests that the long-term business trajectory remains positive despite near-term uncertainties.

About the company 

ICICI Prudential Life Insurance Company Ltd is one of India’s leading private life insurance companies and a joint venture between ICICI Bank and Prudential Corporation Holdings. The company offers a wide range of products including term insurance, savings plans, ULIPs, retirement solutions, and health insurance products. 

It has a strong distribution network across banks, agents, and digital channels, and is known for its focus on technology-driven customer service and long-term financial protection solutions. 

It reported mixed financial performance in Q4FY26. Sales declined sharply by 80% YoY to Rs. 3,185 crore compared to Rs. 15,687 crore in Q4FY25, while EBITDA stood at a loss of Rs. 754 crore against a profit of Rs. 415 crore last year. Despite this, the company delivered strong profitability growth, with net profit rising 62% YoY to Rs. 624 crore and EPS increasing 61% to Rs. 4.30 from Rs. 2.67 in the corresponding period last year. 

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post ICICI Prudential: Will Prudential’s 12% stake sell affect the company’s business? appeared first on Trade Brains.